Mr. Aydinlar is presently the Chairman and Chief Executive Officer of Acibadem Saglik Yatirimlari Holding A.S. ("ASYH"), a 90%-owned subsidiary of IHH. He also serves as the Chairman of the Board of the ASYH group of companies which includes A Plus, Acibadem Project Management, Acibadem Mobile Services and Acibadem Labmed. He is also the Chairman of the Turkish Accredited Hospitals Association. As of 2015, Mr. Aydinlar has been serving on the board of the Foreign Economic Relations Board. This institution is responsible for leading foreign economic relations within the Turkish private sector in a myriad of sectors, as well as for increasing export volume of Turkish businesses and coordinating similar business development activities. A certified public accountant-turned-entrepreneur, Mr. Aydinlar has been recognised for his extensive experience in management and involvement in the healthcare sector since 1993. Being a philanthropist, Mr. Aydinlar is also the Chairman of the Board of Trustees of Acibadem University, an ambitious social responsibility undertaking he initiated to advance healthcare in Turkey through education and research.
Interest
Interest in the securities of IHH as at 27 February 2019: Direct Interest 1) 420,244,132 ordinary shares 2) 665,000 Long Term Incentive Plan (LTIP) units 3) 2,283,000 Enterprise Option Scheme (EOS) options Indirect Interest 107,319,041 ordinary shares
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....